CSPC Pharmaceutical Group Limited (CSPCY)
OTCMKTS
· Delayed Price · Currency is USD
4.460
+0.670 (17.68%)
Jun 6, 2025, 3:17 PM EDT
CSPC Pharmaceutical Group Revenue
CSPC Pharmaceutical Group had revenue of 7.01B CNY in the quarter ending March 31, 2025, a decrease of -21.91%. This brings the company's revenue in the last twelve months to 27.04B, down -16.49% year-over-year. In the year 2024, CSPC Pharmaceutical Group had annual revenue of 29.01B, down -7.76%.
Revenue (ttm)
27.04B CNY
Revenue Growth
-16.49%
P/S Ratio
3.46
Revenue / Employee
1.26M CNY
Employees
21,400
Market Cap
12.90B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 29.01B | -2.44B | -7.76% |
Dec 31, 2023 | 31.45B | 513.21M | 1.66% |
Dec 31, 2022 | 30.94B | 3.07B | 11.02% |
Dec 31, 2021 | 27.87B | 2.92B | 11.73% |
Dec 31, 2020 | 24.94B | 2.84B | 12.84% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
CSPC Pharmaceutical Group News
- 8 days ago - Chinese biotech’s mega drug-licensing deals with multinationals surge - South China Morning Post
- 7 months ago - CSPC Pharmaceutical Group Limited goes ex dividend tomorrow - Seeking Alpha
- 8 months ago - AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline - Benzinga
- 8 months ago - Dow Tumbles Over 400 Points; Duckhorn Portfolio Shares Surge - Benzinga
- 8 months ago - Crude Oil Gains Over 3%; Scholar Rock Shares Spike Higher - Benzinga
- 8 months ago - US Stocks Open Lower; Dow Tumbles Over 150 Points - Benzinga
- 8 months ago - AstraZeneca Inks $1.92B License Pact With Hong Kong-Based Firm To Boost Cardiovascular Pipeline - Benzinga